44222-12-0

Usage

Uses

Used in Chemical Synthesis:
Zinc, iodopropylis used as a catalyst in the chemical synthesis industry for its ability to facilitate the iodination of alkenes and alkynes. Its high selectivity and efficiency in these reactions make it a valuable component in the production of various organic compounds.
Used in Medical Applications:
In the medical field, zinc, iodopropylis used as a treatment for iodine deficiency disorders. Its role in addressing these health issues highlights the importance of iodine in maintaining proper thyroid function and overall health.
Used in Pharmaceutical Industry:
Zinc, iodopropylis used as a reagent in the pharmaceutical industry, where it aids in the synthesis of drugs that require iodine-containing compounds. Its catalytic properties contribute to the development of new medications and the improvement of existing ones.
Used in Research and Development:
In the realm of research and development, zinc, iodopropylis employed as a tool to study the mechanisms of iodination reactions and to explore new methods for synthesizing iodine-containing compounds. This helps in advancing the understanding of chemical reactions and the development of novel applications for Zinc, iodopropyl-.

Downstream Products

• 22319-24-0 2-methyl-hept-2-en-4-one 
• 1678-92-8 propylcyclohexane 
• 589-63-9 octan-4-one 
• 4485-09-0 nonan-4-one 
• 123-19-3 4-heptanone 
• 49770-81-2 methyl 4-oxoheptanoate 
• 130115-41-2 (2R,3R,5R) and (2S,3R,5R)-4-methyl-5-phenyl-3-n-propyl-2-morpholinol 
• 121507-78-6 2,6-trans-6-methyl-1-phenoxycarbonyl-2-propyl-1,2,5,6-tetrahydro-pyridine 
• 121507-78-6 2,6-cis-6-methyl-1-phenoxycarbonyl-2-propyl-1,2,5,6-tetrahydro-pyridine 
• 14548-91-5 5-methyl-2-propyl-[1,3]dioxolan-4-one 
• 53252-20-3 6-methyl-non-6-en-4-one 
• 7036-98-8 6-methyl-non-5-en-4-one 
• 5932-79-6 Propyl-pentyl-carbinol 
• 614-14-2 1-Phenyl-1-butanol 

Relevant academic research and scientific papers

Spectroscopic characterization of (iodomethyl)zinc reagents involved in stereoselective reactions: Spectroscopic evidence that IZnCH2I Is Not Zn(CH2I)2 + ZnI2 in the presence of an ether

We have shown that low-temperature 13C NMR spectroscopy is an extremely powerful technique for characterizing the (iodomethyl)zinc-derived reagents involved in the cyclopropanation reactions. This technique has allowed us to spectroscopically characterize and unambigously differentiate the Furukawa reagent (EtZnCH2I), the Simmons - Smith reagent (IZnCH2I), and the Wittig reagent (Zn(CH2I)2). Unique spectra are obtained for each of these reagents when they are complexed to a chiral diether. We have also demonstrated that TZnCH2I is not converted into Zn(CH2I)2 + ZnI2 in CD2Cl2 in the presence of a chiral complexing agent. Furukawa's reagent "EtZnCH2I", however, is in equilibrium with Et2Zn and Zn(CH2I)2, and it eventually decomposes into PrZnI and EtZnI at room temperature. The decomposition of Zn(CH2I)2 into IZnCH2I and of IZnCH2I into ZnI2 was monitored by NMR. We have also demonstrated that the general trends observed for the various equilibria involving (iodomelhyl)zinc-derived reagents follow those observed with ethylzinc-derived organometallic compounds.